| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 181.056 | 73.745 | 85.351 | 174.499 | 251.708 | 151.849 | 167.738 | 187.337 | 247.391 | 201.184 |
| Total Income - EUR | 181.186 | 75.025 | 85.680 | 174.702 | 252.366 | 151.849 | 170.673 | 189.846 | 247.400 | 201.277 |
| Total Expenses - EUR | 179.078 | 71.986 | 82.044 | 137.279 | 223.717 | 122.342 | 141.788 | 159.385 | 219.149 | 185.298 |
| Gross Profit/Loss - EUR | 2.108 | 3.039 | 3.636 | 37.422 | 28.649 | 29.507 | 28.885 | 30.461 | 28.251 | 15.979 |
| Net Profit/Loss - EUR | 1.645 | 2.509 | 2.780 | 35.675 | 28.203 | 29.318 | 27.178 | 28.848 | 26.150 | 13.771 |
| Employees | 7 | 5 | 5 | 5 | 5 | 6 | 5 | 5 | 6 | 5 |
Check the financial reports for the company - Promed-Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 6.310 | 8.300 | 11.917 | 16.064 | 35.507 | 100.583 | 60.157 | 63.802 | 85.332 | 81.469 |
| Current Assets | 49.112 | 39.668 | 40.059 | 68.981 | 59.979 | 27.714 | 95.679 | 113.578 | 20.867 | 19.973 |
| Inventories | 13.077 | 18.832 | 29.183 | 42.016 | 14.294 | 12.871 | 5.923 | 4.937 | 3.186 | 3.874 |
| Receivables | 35.219 | 20.090 | 10.568 | 25.215 | 36.757 | 12.911 | 83.491 | 106.757 | 9.546 | 2.194 |
| Cash | 816 | 746 | 308 | 1.750 | 8.928 | 1.931 | 6.265 | 1.883 | 8.135 | 13.905 |
| Shareholders Funds | 4.051 | 6.519 | 9.188 | 44.695 | 72.032 | 99.977 | 124.945 | 147.793 | 57.294 | 62.113 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 53.322 | 43.408 | 42.787 | 40.350 | 35.390 | 40.030 | 30.891 | 29.587 | 48.905 | 39.329 |
| Income in Advance | 29 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8130 - 8130" | |||||||||
| CAEN Financial Year |
8130
|
|||||||||
Comments - Promed-Srl